Ron Cohen

Biopharma Consultant

Ron Cohen, M.D. served from 1994-2024 as Founder, President and CEO of Acorda Therapeutics, Inc., a public biotechnology company that developed therapies for disorders of the nervous system, including approved and commercialized therapies for Parkinson’s disease and Multiple Sclerosis. Dr. Cohen previously was an officer of Advanced Tissue Sciences, Inc., a biotechnology company engaged in the growth of human organ tissues for transplantation uses. Dr. Cohen is past Chair of the Board of BIO, of BIO’s Emerging Companies Section, and of the New York Biotechnology Association (NYBIO). He is a recipient of Ernst & Young Entrepreneur of the Year Award for the New York Metropolitan Region, and of the NY CEO Lifetime Achievement Award. Dr. Cohen received his B.A. degree in Psychology from Princeton University, and his M.D. from the Columbia College of Physicians & Surgeons. He completed a residency in Internal Medicine at the University of Virginia Medical Center, and is Board Certified in Internal Medicine.